Charles T Hennemeyer
- Associate Professor, Radiology & Imaging Sci - (Clinical Scholar Track)
Contact
Degrees
- M.D. Medicine
- Saint Louis University School of Medicine, St. Louis, Missouri, United States
- B.S. Major: Biologic Sciences
- Saint Louis University, Saint Louis, Missouri
Work Experience
- Department of Medical Imaging University of Arizona (2014 - Ongoing)
- Department of Medical Imaging University of Arizona (2012 - Ongoing)
- Department of Medical Imaging University of Arizona (2012 - Ongoing)
- St. Lawrence Radiology Associates New York (2010 - 2012)
- Auburn Memorial Hospital (2010 - 2012)
- IR and Diagnostic Groups (2010 - 2011)
- Renaissance Imaging Medical Associates, Inc. (2009 - 2010)
- UCLA Ronald Reagan Medical Center (2006 - 2013)
- UC Santa Monica (2006 - 2013)
- Los Robles Hospital (2006 - 2008)
Awards
- 2018 JVIR Distinguished Laboratory Investigation Award Presentation. Pilot Study of the Safety and Efficacy of Gallbladder Cryoablation in a Porcine Model: Midterm Results. SIR 2019
- Spring 2019
- Castle Connolly Top Doctor
- Spring 2019
- Chair, Interventional Radiology, AZ Radiologic Society, Chapter of the American College of Radiology (ACR)
- Spring 2019
- National Institutes of Health (NIH) Reviewer, Clinical Molecular Imaging and Probe development (CMIP)
- Spring 2018
- Journal Reviewer, BMC Cancer Journal
- Spring 2012
Licensure & Certification
- Board Certification - Nuclear Medicine, American Board of Radiology (2006)
- Board Certification -Diagnostic Radiology, American Board of Radiology (2006)
- Medical License, State of California (2001)
- Medical License, State of California (2006)
- Medical License, State of Arizona (2012)
- CAQ - Certified Vascular and Interventional Radiology (2008)
- Medical License, State of Missouri (2001)
- Medical License, State of Maine (2001)
- Medical License, State of Pennsylvania (2001)
- Medical License;, State of New York (2001)
Interests
Teaching
Vascular and Interventional Radiology training
Research
Medical equipment designing of minimally invasive surgical devicesNeuromodulationNovel image guided medical interventionsVertebral augmentation and spinal painInterventional oncology, novel devices
Courses
2020-21 Courses
-
Diagnostic Radiology
RADI 850A (Spring 2021) -
Vascular Interventional Radi
RADI 850R (Spring 2021)
Scholarly Contributions
Journals/Publications
- More infoPurpose: To prospectively evaluate the safety and effectiveness of gallbladder cryoablation in patients with calculous cholecystitis initially treated with percutaneous drainage. Materials and Methods: High–operative risk patients with calculous cholecystitis treated with cholecystostomy tube drainage underwent gallbladder cryoablation. The primary end points were safety, defined as the absence of procedure-related adverse events during the follow-up period, and clinical success, defined as the absence of symptoms after cholecystostomy tube removal. The secondary end point was imaging success, defined as gallbladder involution on computed tomography (CT) or magnetic resonance (MR) imaging. Results: Ten patients underwent gallbladder cryoablation. Mean age was 71 years (SD ± 10; range, 53–90 years). Mean American Society of Anesthesiologists score was 3 (SD ± 1; range, 2–4), and mean modified Frailty Index was 4 (SD ± 2; range, 1–6). Cholecystostomy tubes were in situ for a mean of 60 days (SD ± 26; range, 18–94 days) prior to cryoablation. Mean duration of clinical follow-up was 563 days (SD ± 152; range, 326–799 days) and of imaging follow-up was 368 days (SD ± 235; range, 66–792 days). One infection and 1 mortality occurred, both in patients with gallstones >20 mm in size, prior pseudomonas infection, and iceball volumes >150 cm3. Institutional review board (IRB) review concluded that the cause of the mortality was a medication allergy. Clinical and imaging success was achieved in 9 of 10 patients. Conclusions: Gallbladder cryoablation may be an effective treatment for high-operative risk patients with calculous cholecystitis initially treated with percutaneous drainage, with 90% clinical and imaging success. Optimization of patient selection is indicated, with particular reference to gallstone size and bacterial colonization.
